Side-by-side comparison of AI visibility scores, market position, and capabilities
Hershey PA chocolate and snacks (NYSE: HSY) ~$10.2B FY2024 revenue; Reese's #1 US candy brand, cocoa inflation $2.5K→$12K/MT crisis, SkinnyPop salty snacks, competing with Mars and Ferrero.
The Hershey Company is a Hershey, Pennsylvania-based confectionery and snacks company — publicly traded on the New York Stock Exchange (NYSE: HSY) as an S&P 500 Consumer Staples component — manufacturing and selling chocolate, candy, mints, gum, and salty snacks through iconic brands including Hershey's (chocolate bars, Kisses), Reese's (peanut butter cups — America's #1 candy brand by revenue), Kit Kat (licensed from Nestlé for the US market), York Peppermint Patties, Jolly Rancher, Ice Breakers, Skinny Pop, Dot's Pretzels, and Pirate's Booty through approximately 18,000 employees in 80+ countries. In fiscal year 2024, Hershey reported net sales of approximately $10.2 billion, with earnings per share significantly compressed by unprecedented cocoa commodity inflation: West African cocoa prices (Ghana and Ivory Coast provide 70%+ of global cocoa supply) surged from $2,500/metric ton in 2022 to over $12,000/metric ton in early 2024 — the highest prices in 50+ years — driven by El Niño-related drought and crop disease (swollen shoot disease) reducing cocoa harvests, creating a chocolate manufacturer cost crisis that Hershey absorbed through price increases and hedging while managing volume declines as consumers resisted higher candy prices. CEO Michele Buck has guided Hershey through the cocoa inflation crisis by implementing 10-15% retail price increases in 2023-2024, reformulating some lower-margin products to reduce cocoa content, and hedging cocoa commodity exposure on a rolling 12-18 month forward basis to smooth out extreme spot price volatility.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.